(RXRX) Recursion - Performance -45% in 12m
RXRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-72.04%
#107 in Peer-Group
Rel. Strength
11.94%
#6572 in Stock-Universe
Total Return 12m
-45.03%
#113 in Peer-Group
Total Return 5y
-83.93%
#95 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 10.87 USD |
| 52 Week Low | 3.97 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 71.54 |
| Buy/Sell Signal +-5 | -1.12 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RXRX (-45%) vs XBI (-8.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.15% | 63.5% | 75.2% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-6.08% | -5.9% | 145% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
5.21% | -3.62% | 44.4% | 26.8 | 13.9 | 0.97 | 0.60% | 41% |
| BIM PA Biomerieux |
1.33% | 35.3% | 6.32% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.92% | -5.61% | -0.67% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
4.8% | 50.8% | -11.3% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
6.36% | 50.8% | -5.76% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
4.53% | 14.3% | 9.9% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: RXRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RXRX
| Total Return (including Dividends) | RXRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.55% | 1.20% | 0.24% |
| 3 Months | -22.38% | -4.86% | 5.41% |
| 12 Months | -45.03% | -8.22% | 10.03% |
| 5 Years | -83.93% | -26.18% | 104.87% |
| Trend Score (consistency of price movement) | RXRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 76.2% | 70.6% | 78.8% |
| 3 Months | -39.8% | 23.6% | 79.5% |
| 12 Months | -60.5% | -80.8% | 43% |
| 5 Years | -65.1% | -53.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #57 | 9.23% | 10.28% |
| 3 Month | #143 | -18.41% | -26.36% |
| 12 Month | #114 | -40.10% | -50.04% |
| 5 Years | #92 | -74.38% | -89.34% |
FAQs
Does Recursion (RXRX) outperform the market?
No,
over the last 12 months RXRX made -45.03%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.22%.
Over the last 3 months RXRX made -22.38%, while XBI made -4.86%.
Performance Comparison RXRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RXRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.7% | 10.3% | -17.4% | -55% |
| US NASDAQ 100 | QQQ | 2.3% | 9.3% | -18.5% | -55% |
| German DAX 40 | DAX | 3% | 13.4% | -33.4% | -72% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.4% | 11.6% | -16.4% | -58% |
| Hongkong Hang Seng | HSI | 4% | 8.5% | -33.8% | -71% |
| India NIFTY 50 | INDA | 2.5% | 10.9% | -17.5% | -44% |
| Brasil Bovespa | EWZ | 2.1% | 10.5% | -38.7% | -54% |
RXRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2% | 9.4% | -22.2% | -68% |
| Consumer Discretionary | XLY | 2.7% | 13% | -9% | -62% |
| Consumer Staples | XLP | 2.2% | 12.5% | -19.2% | -52% |
| Energy | XLE | 1.2% | 4.1% | -24.1% | -47% |
| Financial | XLF | 1.4% | 12.5% | -21.2% | -68% |
| Health Care | XLV | 4.8% | 12.1% | -13.5% | -37% |
| Industrial | XLI | 2.4% | 11.5% | -23.8% | -62% |
| Materials | XLB | 3.3% | 11.4% | -18.6% | -43% |
| Real Estate | XLRE | 2.4% | 10.7% | -20.9% | -58% |
| Technology | XLK | 1.7% | 7.6% | -18.9% | -51% |
| Utilities | XLU | 3% | 13% | -23.9% | -64% |
| Aerospace & Defense | XAR | 1.8% | 5.2% | -36.6% | -87% |
| Biotech | XBI | 3.7% | 9.4% | -6.8% | -37% |
| Homebuilder | XHB | 1.6% | 14.5% | -6.5% | -38% |
| Retail | XRT | 0% | 10% | -12.3% | -48% |
RXRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.4% | -10.5% | -30.3% | -50% |
| Natural Gas | UNG | -5.7% | 6.6% | -27.9% | -38% |
| Gold | GLD | 4.2% | 8.4% | -44.7% | -87% |
| Silver | SLV | 3% | 2% | -38.1% | -62% |
| Copper | CPER | 0.5% | 7% | -34.8% | -53% |
RXRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.1% | 8.9% | -16.3% | -41% |
| iShares High Yield Corp. Bond | HYG | 1.7% | 9.5% | -20.6% | -55% |